Safety and Efficacy of RC-1291 HCl in Patients With Cancer Related Anorexia and Weight Loss

Clinical trial NCT00219817 · COMPLETED

Trial details

NCT number: NCT00219817
Sponsor: Helsinn Therapeutics (U.S.), Inc
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Cancer Cachexia

Start date: 2005-06-01
Primary completion: 2006-10-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.